185 related articles for article (PubMed ID: 15538953)
1. AIDS-defining illnesses among patients with HIV in Singapore, 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS).
Bellamy R; Sangeetha S; Paton NI
BMC Infect Dis; 2004 Nov; 4():47. PubMed ID: 15538953
[TBL] [Abstract][Full Text] [Related]
2. Causes of death among patients with HIV in Singapore from 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS).
Bellamy R; Sangeetha S; Paton NI
HIV Med; 2004 Jul; 5(4):289-95. PubMed ID: 15236619
[TBL] [Abstract][Full Text] [Related]
3. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
4. Incidence and spectrum of AIDS-defining illnesses among persons treated with antiretroviral drugs.
Michaels SH; Clark R; Kissinger P
Clin Infect Dis; 1999 Aug; 29(2):468-9. PubMed ID: 10476778
[No Abstract] [Full Text] [Related]
5. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.
Mocroft A; Sabin CA; Youle M; Madge S; Tyrer M; Devereux H; Deayton J; Dykhoff A; Lipman MC; Phillips AN; Johnson MA
J Acquir Immune Defic Syndr; 1999 Aug; 21(5):401-7. PubMed ID: 10458621
[TBL] [Abstract][Full Text] [Related]
6. Profile of opportunistic infections among HIV-1 infected people in Hong Kong.
Wong KH; Lee SS; Lo YC; Li PC; Ho HF; Sitt WH; Lam TW; Lai KY
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Feb; 55(2):127-36. PubMed ID: 7750052
[TBL] [Abstract][Full Text] [Related]
7. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.
Grabar S; Lanoy E; Allavena C; Mary-Krause M; Bentata M; Fischer P; Mahamat A; Rabaud C; Costagliola D;
HIV Med; 2008 Apr; 9(4):246-56. PubMed ID: 18366449
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
[TBL] [Abstract][Full Text] [Related]
9. Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS.
Chan IS; Neaton JD; Saravolatz LD; Crane LR; Osterberger J
AIDS; 1995 Oct; 9(10):1145-51. PubMed ID: 8519450
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting.
Manosuthi W; Chaovavanich A; Tansuphaswadikul S; Prasithsirikul W; Inthong Y; Chottanapund S; Sittibusaya C; Moolasart V; Termvises P; Sungkanuparph S
J Infect; 2007 Nov; 55(5):464-9. PubMed ID: 17714788
[TBL] [Abstract][Full Text] [Related]
11. Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort.
Dore GJ; Hoy JF; Mallal SA; Li Y; Mijch AM; French MA; Cooper DA; Kaldor JM
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):39-43. PubMed ID: 9377123
[TBL] [Abstract][Full Text] [Related]
12. Co-infection by Cryptococcus neoformans and Mycobacterium avium intracellulare in AIDS. Clinical and epidemiological aspects.
Arastéh K; Cordes C; Futh U; Grosse G; Dietz E; Staib F
Mycopathologia; 1997-1998; 140(3):115-20. PubMed ID: 9691498
[TBL] [Abstract][Full Text] [Related]
13. Severe opportunistic infections in AIDS patients with late-stage disease.
Lifson AR; Olson R; Roberts SG; Poscher ME; Drew WL; Conant MA
J Am Board Fam Pract; 1994; 7(4):288-91. PubMed ID: 7942097
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex. Multicenter AIDS Cohort Study.
Lyles RH; Chu C; Mellors JW; Margolick JB; Detels R; Giorgi JV; Al-Shboul Q; Phair JP
AIDS; 1999 Feb; 13(3):341-9. PubMed ID: 10199224
[TBL] [Abstract][Full Text] [Related]
15. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
[TBL] [Abstract][Full Text] [Related]
16. Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.
Podlasin RB; Wiercinska-Drapalo A; Olczak A; Beniowski M; Smiatacz T; Malolepsza E; Juszczyk J; Leszczyszyn-Pynka M; Mach T; Mian M; Knysz B; Horban A
Infection; 2006 Aug; 34(4):196-200. PubMed ID: 16896577
[TBL] [Abstract][Full Text] [Related]
17. [Management of patients infected by the human immunodeficiency virus (HIV). Report of an expert group].
Delfraissy JF;
Rev Pneumol Clin; 2002 Dec; 58(6 Pt 1):312-40. PubMed ID: 12545131
[No Abstract] [Full Text] [Related]
18. Gender-related differences in the spectrum of HIV disease in the Bayamón area, Puerto Rico.
Miniño A; Gómez MA; Velazquez M; Hunter R
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1139-43. PubMed ID: 9449548
[TBL] [Abstract][Full Text] [Related]
19. AIDS defining diseases in the UK: the impact of PCP prophylaxis and twelve years of change.
Porter K; Fairley CK; Wall PG; Evans BG; Goldberg DJ; Weerasuriya M; Noone A
Int J STD AIDS; 1996 Jul; 7(4):252-7. PubMed ID: 8876355
[TBL] [Abstract][Full Text] [Related]
20. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
